| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | C8 Galactosylceramide (d18:1/8:0) |
|---|
| Description | A synthetic bioactive sphingolipid; increases the amount delivered and toxicity of doxorubicin in cancerous but not non-cancerous cells when incorporated in the nanoliposomal membrane of nanoliposomal-doxorubicin; induces proliferation and cytokine production by splenocytes in vitro (100-1,000 ng/ml); activates NF-κB production in C6 glioma cells (10 μM) |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Galactosylceramide (d18:1/8:0)|GalCer(d18:1/8:0)|N-octanoyl-β-D-Galactosylceramide |
|---|
| Gene, Accession, CAS # | CAS: 41613-16-5 |
|---|
| Catalog # | 24346-10 |
|---|
| Price | |
|---|
| Order / More Info | C8 Galactosylceramide (d18:1/8:0) from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|